A total of 390 breast cancer patients (10.5%) and 131 ovarian cancer patients (14.7%) carried an LP/P variant, mainly in BRCA1 (31.9%) and BRCA2 (26.0%), as shown in Figure 2A and Table 2. This evidence concerns the gene BRCA1 and breast carcinoma.